Sutton Wealth Advisors Inc. Harmony Biosciences Holdings, Inc. Transaction History

Sutton Wealth Advisors Inc.

  • $203 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 07, 2023
SELL
$30.8 - $53.92 $18,972 - $33,214
-616 Closed
0 $0
Q3 2022

Nov 07, 2023
BUY
$42.06 - $55.45 $42 - $55
1 Added 0.16%
616 $27.3 Million
Q2 2022

Nov 07, 2023
BUY
$33.54 - $52.15 $20,392 - $31,707
608 Added 8685.71%
615 $30 Million
Q1 2022

Nov 07, 2023
BUY
$33.14 - $51.13 $231 - $357
7 New
7 $341,000

Others Institutions Holding HRMY

# of Institutions
295
Shares Held
46.2M
Call Options Held
316K
Put Options Held
69.9K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.88B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email